ResearchPod

In Western Sydney, Australia extreme temperature days pose serious health and socio-economic threats to its population. 

Dr Milton Speer and colleagues from the School of Mathematical and Physical Sciences, University of Technology Sydney, Australia aim to quantify and explain what is driving the increasing disparity in extreme maximum summer temperatures between coastal and western inland Sydney.

Read the original research: doi.org/10.3390/cli11040076

For Story Telling Week 2024, we've revisited some past episodes to see how else stories can help summarise science.

Listen to the original episode of Dr Angelica Hagsand of the University of Gothenburg here: https://researchpod.org/behavioural-sciences/eyewitness-testimony-much-alcohol-too-much

 Read their original article: https://doi.org/10.1080/1068316X.2021.1929978

Read more in Research Outreach

Welcome to the Enterprise Sessions 

How do you launch a new business without the necessary infrastructure to support it? If you’re Dr Harry Destecroix you build it yourself. Professor Michele Barbour sits down with the Science Creates Founder to talk about the remarkable success of an ecosystem that combines specialist incubator facilities, a network of strategic partners and a dedicated venture capital fund – and aims to make Bristol a global centre for deep tech. 

⭐Highlights 

• Harry describes his unconventional career journey from University of Bristol PhD student to CEO. 
• Hear about Ziylo, Harry’s initial venture – including securing funding, the role of incubators, technology licensing and the acquisition by pharma giant Novo Nordisk. 
• Harry outlines his approach to building balanced and effective multidisciplinary teams that nurture talent and embrace and emphasise diverse strengths. 
• Get Harry’s take on the entrepreneurial mindset and the importance of taking risks, making mistakes and learning from setbacks. 

🌐 About the Enterprise Sessions 

The Enterprise Sessions bring together a diverse mix of company founders and researchers who talk openly about their personal experiences of forming spin-outs and start-ups, raising capital, academic-industry partnerships and the joys of translating research discoveries into real-world impact.  

The series aims to inform, inspire and challenge myths and stereotypes about research commercialisation and how businesses and universities can work together to tackle society's biggest challenges.  

👍 Like, Share, Subscribe, Explore 

If you found this episode inspiring or informative, please don’t forget to like and share. Visit our website or subscribe to the University of Bristol’s YouTube channel for more Enterprise Sessions.  

https://www.bristol.ac.uk/enterprise-sessions  

 Connect with Science Creates 

Science Creates website: https://sciencecreates.co.uk/ 

SCVC website: https://www.scvc.com/  

Science Creates on LinkedIn: https://www.linkedin.com/company/sciencecreates/ 

SCVC on LinkedIn: https://www.linkedin.com/company/sc-vc  

Science Creates on X: https://twitter.com/sciencecreates 

SCVC on X: https://twitter.com/SCVC_UK  

Nanomaterials are small particles that can be found everywhere, including in the air we breathe, which can have detrimental effects on health and the environment.

Dr Ernesto Alfaro-Moreno of the International Iberian Nanotechnology Laboratory in Braga, Portugal, has been involved in continued research on the toxicology of nanomaterials, with promising application in our daily lives. 

Read more in Research Outreach

Read the original research: doi.org/10.1186/s12989-023-00530-0

On the face of it, investment management is purely a numbers game. But behind the scenes, equity analysts require a lot of people skills to get an accurate stock valuation out to the fund management community. 

Dr An-Ping Lin, Associate Professor at Singapore Management University, and colleagues from the US and Canada have produced the very first large-scale, statistical study on why and how much interpersonal, social skills contribute to being a successful analyst in the high stakes world of professional stock market investing.

Read the original paper:  https://doi.org/10.1111/1911-3846.12855

Many of the latest anti-cancer drugs are targeted towards the tiniest molecular differences in cells. But even if you know the genetic make up of a tumour, getting medicines to - and then in to - the affected area is a different challenge.

Dr Moutih Rafei at Defence Therapeutics reports on a novel drug technology that gets more treatment to the cells that need it,  and what that might mean for the future of designing, trialling, and marketing medicines.

Read the original research: https://doi.org/10.1111/cas.15985

Mobile devices have become pervasive in reach and constant in attention. What role does that availability have as a cause of, and potential solution to, crises in mental health and the care profession? And who falls between the cracks where technology falls short?

Dr Dianne Wepa from Charles Darwin University joins us again along side Dr Jabin from the University of Bradford to talk tech, therapy and professional care. 

This episode includes discussion of suicide. Listener discretion is advised.

Read the original article: https://doi.org/10.1177/20552076231174307

Listen to their previous episode: https://doi.org/10.5281/zenodo.10213208

Cigarette smoking increases the risk of developing lung cancer and other diseases, but how effective are public health strategies?

Professor Theodore Holford at the Yale School of Public Health, USA, is part of the CISNET Lung Cancer Working Group. His work uses population health models, such as the Smoking History Generator, to show age-period-cohort effects on smoking rates across US states.

Read more in Research Features

Read the original research: doi.org/10.1016/j.amepre.2022.08.018

While Scotland has been a beacon of hope for many Syrian refugees, resettlement can create a grievous sense of loss and emptiness for many.

Associate Professor Fawad Khaleel of Edinburgh Napier University and Dr Alija Avudukic of Al-Maktoum College, Scotland, UK, examine the challenges faced by people from Syria, who experienced forced displacement from their home country due to war and were re-placed in Scotland. 

The original research is still under review and will be published soon.

Follow Dr Khaleel on LinkedIn

Does a firms age and size matter in the world of Initial Public Offerings?

Smader Siev from Ono Academic College and Mahmoud Qadan from the the University of Haifa, have explored the dynamic landscape of Initial Public Offerings, and demonstrated how age and size play pivotal roles in the IPO world.

Read the original research: doi.org/10.3390/jrfm15120586